WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2022. Fourth Quarter and Full Year 2022 Highlights Fourth quarter revenue grew 7% to $11.45 billion. Fourth quarter GAAP diluted earnings per share (EPS) was... Read more
BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2022 financial results before market opening on Thursday, February 9, 2023. The Company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time to discuss the results and current business trends. To listen to the... Read more
WASHINGTON, Jan. 24, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the fourth quarter and full year 2022. All results in this release reflect only continuing operations unless otherwise noted. Net earnings refers to net earnings attributable to common shareholders. For the quarter ended December 31, 2022, net earnings were... Read more
ANDOVER, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that the Company will release fourth quarter and full year 2022 financial results after market close on Monday, February 13, Read more
WASHINGTON, Dec. 27, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2022 on Tuesday, January 24, 2023 beginning at 8:00 a.m. ET and lasting approximately 1 hour. During the call, the company will discuss its financial performance, as well as future expectations.... Read more
AIR Recon DL is GE Healthcare’s pioneering deep-learning based technology that provides for clinical efficiency by enabling shorter scan times with higher resolution in MRI clinical procedures. Chicago, US — November 30, 2022 – GE Healthcare announced today that it was recognized in the annual ‘Best of What’s New’ awards by Popular Science Magazine. The... Read more
Capacity expansion at Active Pharmaceutical Ingredient facility in Lindesnes, Norway, contributes to GE Healthcare’s aim to produce 30 million more doses of contrast media per year by 2025 This step reinforces GE Healthcare’s broader commitment to address growing future demand for contrast media, which it expects to double in the next ten years Lindesnes, 17... Read more